|
High grade B-cell
gastric lymphoma with complete pathologic remission after
eradication of Helicobacter pylori infection: report of a case and
review of the literature.
World J Surg Oncol. 2008 Mar 19;6:35.
BACKGROUND:
Treatment of primary gastric diffuse large B-cell lymphoma is
still controversial. The treatment of localized disease was based
on surgery alone, or followed by chemotherapy and/or radiotherapy.
High-grade gastric lymphomas are generally believed to be
Helicobacter pylori (HP)-independent growing tumors. However a few
cases of regression of high-grade gastric lymphomas after the cure
of Helicobacter pylori infection had been described. CASE
PRESENTATION: We report here a case with primary diffuse large
B-cell lymphoma that showed a complete pathologic remission after
HP eradication and we reviewed the literature. A computerized
literature reach through Medline, Cancerlit and Embase were
performed, applying the words: high grade gastric lymphoma, or
diffuse large B cell, MALT gastric lymphoma, DLBCLL (MALT)
lymphoma and Helicobacter. Articles and abstracts were also
identified by back-referencing from original and relevant papers.
Selected for the present review were papers published in English
before January 2007. CONCLUSION: Forty two cases of primary high
grade gastric lymphoma that regressed with anti HP treatment were
found. There were anecdotal cases reported and patients belonging
to prospective studies; four trials studied the effect of
eradication of Helicobacter pylori as first line therapy in high
grade gastric lymphoma: 22 of a total of 38 enrolled patients
obtained complete remission. Depth of gastric wall infiltration
and clinical stage were important factors to predict the response
to antibiotic therapy. Our case and the review of the literature
show that high-grade transformation is not necessarily associated
with the loss HP dependence. In early stage, for high-grade B-cell
HP-positive gastric lymphomas, given the limited toxicity of
anti-HP therapy, this treatment may be considered as one of the
first line treatment options.
|